Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Coronary Artery Disease peptide trials
4 selected ClinicalTrials.gov records carrying the official condition label Coronary Artery Disease. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
4 selected records.
2 profiles.
2009–2017 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 60 selected PubMed records and 29 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Coronary Artery Disease unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00111566
PeptideScanner retained ClinicalTrials.gov record NCT00111566 at 2026-11-15T21:59:29.646Z. Its registry update date was 2013-11-28, and PeptideScanner's reviewed identity mapping was eptifibatide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- November 28, 2013
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00448461
PeptideScanner retained ClinicalTrials.gov record NCT00448461 at 2026-11-15T21:58:19.888Z. Its registry update date was 2009-02-10, and PeptideScanner's reviewed identity mapping was bivalirudin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- February 10, 2009
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01848899
PeptideScanner retained ClinicalTrials.gov record NCT01848899 at 2026-11-15T21:58:19.888Z. Its registry update date was 2016-04-06, and PeptideScanner's reviewed identity mapping was bivalirudin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 6, 2016
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Bivalirudin · 2017-02-03
ClinicalTrials.gov record NCT02384070
Completed at the retained observation.
Open attributed record →Bivalirudin · 2016-04-06
ClinicalTrials.gov record NCT01848899
Completed at the retained observation.
Open attributed record →Eptifibatide · 2013-11-28
ClinicalTrials.gov record NCT00111566
Completed at the retained observation.
Open attributed record →Bivalirudin · 2009-02-10
ClinicalTrials.gov record NCT00448461
Completed at the retained observation.
Open attributed record →